Evidence map›Paper›PMID 34468743›Full record

Trial reportJournal of the Pediatric Infectious Diseases Society2021

Etiology and Incidence of Moderate-to-Severe Diarrhea in Young Children in Niger.

James A Platts-Mills, Eric R Houpt, Jie Liu, Jixian Zhang, Ousmane Guindo, Nathan Sayinzoga-Makombe, Timothy L McMurry, Sarah Elwood, Céline Langendorf, Rebecca F Grais and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the Pediatric Infectious Diseases Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Consequences of Shigella infection in young children: a systematic review.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Pooled it
  3. Trial
  4. Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Could aVaccine: X · 2022
    Article
  16. PivotalVaccines · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

James A Platts-MillsDivision of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA.ORCID 0000-0002-4956-0418
Eric R HouptDivision of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA.
Jie LiuDivision of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA.
Jixian ZhangDivision of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA.
Ousmane GuindoEpicentre, Niamey, Niger.
Nathan Sayinzoga-MakombeEpicentre, Niamey, Niger.
Timothy L McMurryDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Sarah ElwoodDivision of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA.
Céline LangendorfDepartment of Research, Epicentre, Paris, France.
Rebecca F GraisDepartment of Research, Epicentre, Paris, France.
Sheila IsanakaDepartment of Research, Epicentre, Paris, France.

Funding

Bill and Melinda Gates Foundation OPP1179069
6 · The paper itself

Abstract

backgroundHigh-resolution data on the etiology of childhood diarrhea in countries with the highest burden and mortality remain sparse and are needed to inform burden estimates and prioritize interventions.

methodsWe tested stool specimens collected between October 2014 and December 2017 from children under 2 years of age from the per-protocol population of a placebo-controlled clinical trial of a bovine rotavirus pentavalent vaccine (Rotasiil) in Niger. We tested 1729 episodes of moderate-to-severe diarrhea (Vesikari score ≥ 7) using quantitative PCR and estimated pathogen-specific burdens by age, season, severity, and trial intervention arm.

resultsThe 4 pathogens with the highest attributable incidence of diarrhea were Shigella (7.2 attributable episodes per 100 child-years; 95% confidence interval: 5.2, 9.7), Cryptosporidium (6.5; 5.8, 7.2), rotavirus (6.4; 5.9, 6.7), and heat-stabile toxin-producing enterotoxigenic Escherichia coli (ST-ETEC) (6.2; 3.1, 7.7). Cryptosporidium was the leading etiology of severe diarrhea (Vesikari score ≥ 11) and diarrhea requiring hospitalization. Shigella was the leading etiology of diarrhea in children 12-23 months of age but also had a substantial burden in the first year of life, with 60.5% of episodes of severe shigellosis occurring in infants. Shigella, Cryptosporidium, and ST-ETEC incidence peaked during the warmer and wetter period and coincided with peak all-cause diarrhea incidence.

conclusionsIn this high-burden setting, the leading diarrheal pathogens were Shigella, Cryptosporidium, rotavirus, and ST-ETEC, and each was disproportionately seen in infants. Vaccine development should target these pathogens, and the impact of vaccine schedule on diarrhea burden in the youngest children will need to be considered.

Indexed as

DiarrheaCryptosporidiosisCryptosporidiumHumansIncidenceInfantNigerVaccine DevelopmentchildrenCryptosporidiumdiarrhearotavirusShigella

Identifiers

PMID34468743
PMCPMC8719619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.